Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2025-11-06 00:00:00 ET · period of report 2025-11-04 · accession 0001104659-25-107806 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-06 | 2025-11-04 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | A - Grant | $0.00 | +9,855 | 193.6K | +5% | $0 |
| D | 2025-11-06 | 2025-11-04 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | A - Grant | $0.00 | +13.4K | 13.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2025-11-04 | A | A | 9,855 | $0.00 | 193,581 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | A | A | 13,367 | $0.00 | 13,367 | D | $7.61 · — to 2035-11-03 | 13,367 Series A Common Stock | (F2) This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date. |